$0.2400
0.01818.16%
Last update: Nov 10, 4:08 AM
Traws Pharma Inc
TRAWNASDAQ
The average analyst price target for Traws Pharma is $1, 334.8% above the current price. Of 2 analysts, 2 rate it Hold. The latest change came on Jun 18, 2026, when HC Wainwright & Co. downgraded Traws Pharma from Buy to Neutral with a $1 price target.
Price Target Range — 3 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
